FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dorothy Crawford

Research Profile

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Risk Factors

Co-author Network

Publications

TOP 3
Ingolfur Johannessen; G Urquhart; S L Watson; P Wingate; L Bieleski; Tanzina Haque; Dorothy H Crawford
Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
Karen F Macsween; Craig D Higgins; Karen McAulay; Hilary Williams; Nadine Harrison; Anthony J Swerdlow; Dorothy H Crawford
Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease.
Karen McAulay; Tanzina Haque; Dorothy H Crawford
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dorothy Crawford (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ingolfur Johannessen; G Urquhart; S L Watson; P Wingate; L Bieleski; Tanzina Haque; Dorothy H Crawford
Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
Journal of medical virology 2011;83(9):1585-96.
2010: Karen F Macsween; Craig D Higgins; Karen McAulay; Hilary Williams; Nadine Harrison; Anthony J Swerdlow; Dorothy H Crawford
Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(5):699-706.
2009: Karen McAulay; Tanzina Haque; Dorothy H Crawford
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.
British journal of cancer 2009;101(6):1019-27.
2009: Victoria J Vanhoutte; Karen A McAulay; Erin McCarrell; Marc Turner; Dorothy H Crawford; Tanzina Haque
Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
Immunology 2009;127(4):577-86.
2009: P J Wingate; Karen McAulay; Iain C Anthony; Dorothy H Crawford
Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Journal of medical virology 2009;81(5):870-7.
2009: Karen A McAulay; Tanzina Haque; Gillian Urquhart; Christopher Bellamy; Deisy Guiretti; Dorothy H Crawford
Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(6):3892-901.
2007: Karen McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.
The Journal of clinical investigation 2007;117(10):3042-8.
2007: Tanzina Haque; Gwen M Wilkie; Marie M Jones; Craig D Higgins; Gillian Urquhart; Phoebe Wingate; David Burns; Karen McAulay; Marc Turner; Christopher Bellamy; Peter L Amlot; Deirdre Kelly; Alastair MacGilchrist; Maher K Gandhi; Anthony J Swerdlow; Dorothy H Crawford
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.
Blood 2007;110(4):1123-31.
2007: Maher K Gandhi; Gwen M Wilkie; Ujjwal Dua; Peter Mollee; Karen Grimmett; T Williams; N Whitaker; Devinder Gill; Dorothy H Crawford
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1293-9.
2007: Craig D Higgins; Anthony J Swerdlow; Karen F Macsween; Nadine Harrison; Hilary Williams; Karen McAulay; Ranjit Thomas; Stuart Reid; Margaret Conacher; Kathryn Britton; Dorothy H Crawford
A study of risk factors for acquisition of Epstein-Barr virus and its subtypes.
The Journal of infectious diseases 2007;195(4):474-82.
2006: Tanzina Haque; Ingolfur Johannessen; Dilani Dombagoda; Chandrya Sengupta; David M Burns; Pru Bird; Geoff Hale; Giorgina Mieli-Vergani; Dorothy H Crawford
A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.
The Journal of infectious diseases 2006;194(5):584-7.
2006: Ranjit Thomas; Karen F Macsween; Karen McAulay; Daniel Clutterbuck; Richard Anderson; Stuart Reid; Craig D Higgins; Anthony J Swerdlow; Nadine Harrison; Hilary Williams; Dorothy H Crawford
Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions.
Journal of medical virology 2006;78(9):1204-9.
2006: Dorothy H Crawford; Karen F Macsween; Craig D Higgins; Ranjit Thomas; Karen McAulay; Hilary Williams; Nadine Harrison; Stuart Reid; Margaret Conacher; Jill Douglas; Anthony J Swerdlow
A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(3):276-82.
2006: Hilary Williams; Dorothy H Crawford
Epstein-Barr virus: the impact of scientific advances on clinical practice.
Blood 2006;107(3):862-9.
2005: Margaret Conacher; Robin Callard; Karen McAulay; Helen Chapel; David Webster; Dinakantha S Kumararatne; Anita Chandra; Gavin Spickett; Paul A Hopwood; Dorothy H Crawford
Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.
Journal of virology 2005;79(17):11128-34.
2005: Ranjit V Thomas; Karen McAulay; Craig Higgins; Gwen M Wilkie; Dorothy H Crawford
Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease.
Blood 2005;106(4):1502-3; author reply 1503.
2005: Robert F Wynn; Peter Arkwright; Tanzina Haque; Maged I Gharib; Gwen M Wilkie; Marie Morton-Jones; Dorothy H Crawford
Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.
The lancet oncology 2005;6(5):344-6.
2005: Hilary Williams; Karen McAulay; Karen F Macsween; Neil J Gallacher; Craig D Higgins; Nadine Harrison; Anthony J Swerdlow; Dorothy H Crawford
The immune response to primary EBV infection: a role for natural killer cells.
British journal of haematology 2005;129(2):266-74.
2004: Simon J Talbot; Dorothy H Crawford
Viruses and tumours--an update.
European journal of cancer (Oxford, England : 1990) 2004;40(13):1998-2005.
2004: David M Burns; Dorothy H Crawford
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Blood reviews 2004;18(3):193-209.
2004: Gwen M Wilkie; Clare Taylor; Marie M Jones; David M Burns; Marc Turner; David Kilpatrick; Peter L Amlot; Dorothy H Crawford; Tanzina Haque
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(4):309-16.
2003: Craig D Higgins; Anthony J Swerdlow; John D Smith; Beverley J Hunt; J Alero Thomas; Margaret M Burke; Dorothy H Crawford; Magdi H Yacoub
Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching.
Transplantation 2003;75(10):1698-703.
2003: Karen F Macsween; Dorothy H Crawford
Epstein-Barr virus-recent advances.
The Lancet infectious diseases 2003;3(3):131-40.
2002: Dorothy H Crawford; Anthony J Swerdlow; Craig Higgins; Karen McAulay; Nadine Harrison; Hilary Williams; Kathryn Britton; Karen F Macsween
Sexual history and Epstein-Barr virus infection.
The Journal of infectious diseases 2002;186(6):731-6.
2002: Tanzina Haque; Gwen M Wilkie; Clare Taylor; Peter L Amlot; Parvez Murad; Angela Iley; Dilani Dombagoda; Kate M Britton; Anthony J Swerdlow; Dorothy H Crawford
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
Lancet 2002;360(9331):436-42.
2002: Paul A Hopwood; Louise Brooks; Rachael Parratt; Beverly J Hunt; Maria Bokhari; J Alero Thomas; Magdi Yacoub; Dorothy H Crawford; Bokhari Maria; Thomas J Alero; Yacoub Magdi
Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.
Transplantation 2002;74(2):194-202.
2002: Ingolfur Johannessen; Sunimali M Perera; Alice Gallagher; Paul A Hopwood; J Alero Thomas; Dorothy H Crawford
Expansion in scid mice of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease biopsy material.
The Journal of general virology 2002;83(Pt 1):173-8.
2001: Tanzina Haque; Clare Taylor; Gwen M Wilkie; P Murad; Peter L Amlot; Sue V Beath; Patrick J McKiernan; Dorothy H Crawford
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.
Transplantation 2001;72(8):1399-402.
2000: Ingolfur Johannessen; M Asghar; Dorothy H Crawford
Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice.
British journal of haematology 2000;109(3):600-10.
2000: P Hopwood; Dorothy H Crawford
The role of EBV in post-transplant malignancies: a review.
Journal of clinical pathology 2000;53(4):248-54.
2000: G C Faulkner; Andrew S Krajewski; Dorothy H Crawford
The ins and outs of EBV infection.
Trends in microbiology 2000;8(4):185-9.
2000: Anthony J Swerdlow; Craig D Higgins; B J Hunt; J Alero Thomas; M M Burke; Dorothy H Crawford; M H Yacoub
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.
Transplantation 2000;69(5):897-904.
1999: Ingolfur Johannessen; Dorothy H Crawford
In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD).
Reviews in medical virology 1999;9(4):263-77.
1999: Tanzina Haque; Dorothy H Crawford
The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation.
British journal of haematology 1999;106(2):309-16.
1999: G C Faulkner; S R Burrows; R Khanna; Denis Moss; A G Bird; Dorothy H Crawford
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.
Journal of virology 1999;73(2):1555-64.
1998: Ingolfur Johannessen; Tanzina Haque; J N'Jie-Jobe; Dorothy H Crawford
Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.
The Journal of general virology 1998;79 ( Pt 7)():1631-6.
1998: Tanzina Haque; Peter L Amlot; N Helling; J Alero Thomas; P Sweny; K Rolles; A K Burroughs; H Grant Prentice; Dorothy H Crawford
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6204-9.
1998: S M Perera; J Alero Thomas; M Burke; Dorothy H Crawford
Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
The Journal of pathology 1998;184(2):177-84.
1998: Tanzina Haque; Dorothy H Crawford
Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
Springer seminars in immunopathology 1998;20(3-4):375-87.
1997: Tanzina Haque; Dorothy H Crawford
PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material.
The Journal of general virology 1997;78 ( Pt 12)():3357-60.
1997: Tanzina Haque; J Alero Thomas; R Parratt; B J Hunt; M H Yacoub; Dorothy H Crawford
A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Transplantation 1997;64(7):1028-34.
1997: LJ Nicholson; Paul A Hopwood; Ingolfur Johannessen; JR Salisbury; J Codd; D Thorley-Lawson; Dorothy H Crawford
Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells.
Oncogene 1997;15(3):275-83.
1996: Tanzina Haque; J Alero Thomas; K I Falk; RN Parratt; B J Hunt; M Yacoub; Dorothy H Crawford
Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients.
The Journal of general virology 1996;77 ( Pt 6)():1169-72.
1996: Tanzina Haque; P Iliadou; A Hossain; Dorothy H Crawford
Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.
Journal of medical virology 1996;48(1):17-21.
1995: Dorothy H Crawford; J Alero Thomas; C D Gregory; D Catovsky; K Chaggar
Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Leukemia 1995;9(5):747-53.
1995: L Karimi; Dorothy H Crawford; Samuel H Speck; L J Nicholson
Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus.
The Journal of general virology 1995;76 ( Pt 4)():759-65.
1994: K M Lam; H Whittle; M Grzywacz; Dorothy H Crawford
Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients.
Immunology 1994;82(3):383-8.
1994: Dorothy H Crawford; S Chen; C A Boyd
Cationic amino acid transport in human T lymphocytes is markedly increased in the CD45RA, CD8+ population after activation.
Immunology 1994;82(3):357-60.
1994: M G Doyle; Dorothy H Crawford
Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Intervirology 1994;37(5):236-44.
1993: M G Doyle; D Catovsky; Dorothy H Crawford
Infection of leukaemic B lymphocytes by Epstein Barr virus.
Leukemia 1993;7(11):1858-64.
1993: J C Luxton; Ian Williams; I Weller; Dorothy H Crawford
Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment.
AIDS (London, England) 1993;7(10):1337-43.
1993: Dorothy H Crawford; D Catovsky
In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Immunology 1993;80(1):40-4.
1993: N A Hotchin; N Wedderburn; I Roberts; J Alero Thomas; J A Bungey; B Naylor; Dorothy H Crawford
Analysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene.
British journal of cancer 1993;67(5):926-32.
1993: M J Allday; Dorothy H Crawford; J Alero Thomas
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
The Journal of general virology 1993;74 ( Pt 3)():361-9.
1992: Dorothy H Crawford
Epstein-Barr virus: does it cause cancer?
The Journal of tropical medicine and hygiene 1992;95(4):229-38.
1991: K M Lam; N Syed; H Whittle; Dorothy H Crawford
Circulating Epstein-Barr virus-carrying B cells in acute malaria.
Lancet 1991;337(8746):876-8.
1991: K M Lam; Dorothy H Crawford
The oncogenic potential of Epstein-Barr virus.
Critical reviews in oncogenesis 1991;2(3):229-45.